These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21151927)

  • 1. Stressed-induced TMEM135 protein is part of a conserved genetic network involved in fat storage and longevity regulation in Caenorhabditis elegans.
    Exil VJ; Silva Avila D; Benedetto A; Exil EA; Adams MR; Au C; Aschner M
    PLoS One; 2010 Dec; 5(12):e14228. PubMed ID: 21151927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
    Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
    PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
    Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
    J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.
    Tucci S
    J Inherit Metab Dis; 2017 May; 40(3):317-323. PubMed ID: 28247148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disrupted fat distribution and composition due to medium-chain triglycerides in mice with a β-oxidation defect.
    Tucci S; Flögel U; Sturm M; Borsch E; Spiekerkoetter U
    Am J Clin Nutr; 2011 Aug; 94(2):439-49. PubMed ID: 21697078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of mitochondrial bioenergetics and permeability transition induction caused by major long-chain fatty acids accumulating in VLCAD deficiency in skeletal muscle as potential pathomechanisms of myopathy.
    Cecatto C; Amaral AU; Roginski AC; Castilho RF; Wajner M
    Toxicol In Vitro; 2020 Feb; 62():104665. PubMed ID: 31629068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fate of medium-chain fatty acids in very long-chain acyl‑CoA dehydrogenase deficiency (VLCADD): A matter of sex?
    Wehbe Z; Alatibi K; Jellusova J; Spiekerkoetter U; Tucci S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1591-1605. PubMed ID: 31394165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice.
    Primassin S; Tucci S; Spiekerkoetter U
    Mol Genet Metab; 2011 Dec; 104(4):546-51. PubMed ID: 21963783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy.
    Keeler AM; Conlon T; Walter G; Zeng H; Shaffer SA; Dungtao F; Erger K; Cossette T; Tang Q; Mueller C; Flotte TR
    Mol Ther; 2012 Jun; 20(6):1131-8. PubMed ID: 22395529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.
    Gélinas R; Thompson-Legault J; Bouchard B; Daneault C; Mansour A; Gillis MA; Charron G; Gavino V; Labarthe F; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H813-23. PubMed ID: 21685264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers.
    Seminotti B; Leipnitz G; Karunanidhi A; Kochersperger C; Roginskaya VY; Basu S; Wang Y; Wipf P; Van Houten B; Mohsen AW; Vockley J
    Hum Mol Genet; 2019 Mar; 28(6):928-941. PubMed ID: 30445591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models.
    Diekman EF; van Weeghel M; Wanders RJ; Visser G; Houten SM
    FASEB J; 2014 Jul; 28(7):2891-900. PubMed ID: 24648546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
    Tucci S; Behringer S; Spiekerkoetter U
    FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.
    Xiong D; He H; James J; Tokunaga C; Powers C; Huang Y; Osinska H; Towbin JA; Purevjav E; Balschi JA; Javadov S; McGowan FX; Strauss AW; Khuchua Z
    Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H326-38. PubMed ID: 24285112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice and the development of evidence.
    Wilcken B
    J Inherit Metab Dis; 2012 Jan; 35(1):3-4. PubMed ID: 21863278
    [No Abstract]   [Full Text] [Related]  

  • 16. AAV9 gene replacement therapy for respiratory insufficiency in very-long chain acyl-CoA dehydrogenase deficiency.
    Zieger M; Keeler AM; Flotte TR; ElMallah MK
    J Inherit Metab Dis; 2019 Sep; 42(5):870-877. PubMed ID: 30993714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propionyl-CoA carboxylase pcca-1 and pccb-1 gene deletions in Caenorhabditis elegans globally impair mitochondrial energy metabolism.
    Chapman KA; Ostrovsky J; Rao M; Dingley SD; Polyak E; Yudkoff M; Xiao R; Bennett MJ; Falk MJ
    J Inherit Metab Dis; 2018 Mar; 41(2):157-168. PubMed ID: 29159707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite accumulation in VLCAD deficiency markedly disrupts mitochondrial bioenergetics and Ca
    Cecatto C; Amaral AU; da Silva JC; Wajner A; Schimit MOV; da Silva LHR; Wajner SM; Zanatta Â; Castilho RF; Wajner M
    FEBS J; 2018 Apr; 285(8):1437-1455. PubMed ID: 29476646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.
    Yamada K; Taketani T
    J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of valinomycin in fibroblasts from patients with fatty acid oxidation disorders.
    Ndukwe Erlingsson UC; Iacobazzi F; Liu A; Ardon O; Pasquali M; Longo N
    Biochem Biophys Res Commun; 2013 Aug; 437(4):637-41. PubMed ID: 23867825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.